Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126551782 | 12655178 | 2 | F | 20160921 | 20160816 | 20160930 | EXP | US-NOVOPROD-505071 | NOVO NORDISK | 58.00 | YR | A | F | Y | 0.00000 | 20160930 | MD | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126551782 | 12655178 | 1 | SS | VICTOZA | LIRAGLUTIDE | 1 | Subcutaneous | UNKNOWN | UNKNOWN | 0 | SOLUTION FOR INJECTION | ||||||||
| 126551782 | 12655178 | 2 | PS | NOVOLOG | INSULIN ASPART | 1 | Subcutaneous | UNKNOWN | UNKNOWN | 20986 | SOLUTION FOR INJECTION |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 126551782 | 12655178 | 1 | Type 2 diabetes mellitus |
| 126551782 | 12655178 | 2 | Type 2 diabetes mellitus |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 126551782 | 12655178 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 126551782 | 12655178 | Diabetic neuropathy | |
| 126551782 | 12655178 | Diabetic retinopathy |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| no results found |